Changes of Tumor Markers in Patients with Breast Cancer during Postoperative Adjuvant Chemotherapy

Table 3

Correlation between CA153 levels and clinicopathological factors at initial diagnosis.

Factor	CA153 value U/mL ()	Univariate analysis		Multivariate analysis
		F	P	F	P
Age
≤57		0.019	0.890
>57
Menstruation
Yes		0.277	0.600
No
Comorbidities
No		1.709	0.194
Yes
BMI
≤24		0.008	0.929
>24
Tumor size
≤2 cm		0.331	0.567
>2 cm
Nodal status
0		1.568	0.214
1-3
≥4
HR status
Positive		0.029	0.865
Negative
ALT at initial diagnosis
≤15		0.089	0.767
>15
AST at initial diagnosis
≤20		0.819	0.368
>20
rGT at initial diagnosis
≤16		1.156	0.285
>16
Triglycerides at initial diagnosis
≤1.09		0.107	0.744
>1.09
Cholesterol at initial diagnosis
≤4.62		1.430	0.235
>4.62
Fasting blood glucose at initial diagnosis
≤4.88		0.080	0.778
>4.88
WBC
≤6.27		1.962	0.165
>6.27
NEUT at initial diagnosis
≤3.50		1.575	0.213
>3.50
MONO at initial
≤0.29		0.459	0.500
>0.29
LY at initial diagnosis
≤1.95		0.008	0.928
>1.95
PLT/LY at initial diagnosis
≤117.54		0.013	0.910
>117.54
NEUT/LY at initial diagnosis
≤1.74		1.602	0.209
>1.74
LY/MONO at initial diagnosis
≤6.61		0.381	0.538
>6.61
SII at initial diagnosis
≤410.69		5.049	0.027	5.049	0.027
>410.69